U.S. Moves to Block DNA-Sequencing Deal on Competition Fears

(Bloomberg) -- U.S. antitrust enforcers moved to block the merger of two DNA-sequencing firms -- Illumina Inc. and Pacific Biosciences of California Inc. -- saying the deal would harm competition.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.